| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.3M | -12.3% |
| Cost of Revenue | $4.0M | -15.1% |
| Gross Profit | $1.3M | -2.2% |
| R&D Expense | $171K | -53.0% |
| SG&A Expense | $4.3M | -13.6% |
| Operating Income | -$3.2M | +20.7% |
| Pre-tax Income | -$3.2M | +19.8% |
| Income Tax | $30K | -5.9% |
| Net Income | -$3.2M | +19.7% |
| EPS (Basic) | -$0.88 | +51.4% |
| EPS (Diluted) | -$0.88 | +51.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | +96.1% |
| Accounts Receivable | $257K | -79.9% |
| Inventory | $236K | +59.3% |
| Current Assets | $6.2M | +22.5% |
| Total Assets | $6.4M | +24.1% |
| Current Liabilities | $1.3M | -44.8% |
| Long-term Debt | $393K | +4.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +54.1% |
| Investing Cash Flow | -$3K | +0.0% |
| Financing Cash Flow | $4.6M | +101.6% |
| $4.8M |
| +90.8% |